Menu

Widespread Data Duplication

Around one out of every four cancer papers scrutinized in a recent study contains questionable figures, and journals and authors aren’t responding to requests for clarification.

Jun 17, 2015
Kerry Grens

WIKIMEDIA, MAGNUS MANSKE

Of a sampling of 120 papers from three cancer-related journals, around 25 percent contained what appeared to be duplicated images, according to an analysis from Oslo University Hospital’s Morten Oksvold. At least half of these images were duplicates from different experiments, and the most common problem was the duplication of loading controls in Western blots.

Oksvold contacted both the authors of the papers in question and the respective journal editors in October 2014, yet by May 2015, “no editorial replies have been received so far,” he wrote in his report, published in Science and Engineering Ethics last week (June 12).

“This is just indefensible,” according to Discover’s Neuroskeptic. “Oksvold’s allegations deserve to be taken seriously.”

Oksvold had collected 40 papers continuously as they were published in the three journals—reportedly, Cancer Cell, International Journal of Oncology, and Oncogene—beginning in late 2013. All suspicions of duplication were sent to a second scientist for confirmation, he noted.

This February, Oksvold posted his observations to the post-publication peer review site PubPeer, and two authors responded over the course of a month. Both explained that the mistakes were honest errors.                                                                              

Oksvold pointed out in his paper that it’s impossible to tell from his analysis whether any of the duplications were due to accidental slip-ups, sloppiness, or intentional misconduct. Some commenters on PubPeer also stated that some duplications could be appropriate. “It is absolutely OK to show the same data on a different page in a larger context, for readability reasons or simply to make a related argument,” wrote one anonymous poster. Yet, without replies from authors or editors, the cases go unresolved.

“There is an obvious need for reforms in the peer reviewing and erratum/retraction system,” Oksvold wrote in his paper. “If no action is taken it seems clear that over time, the public confidence in science and research could entirely erode away.” 

June 2019

Living with Bacteria

Can pathogens be converted to commensals?

Marketplace

Sponsored Product Updates

New-Generation Incubator Brings the Latest Technology to Mid-Capacity Microplate Cell Culture
New-Generation Incubator Brings the Latest Technology to Mid-Capacity Microplate Cell Culture
New Thermo Scientific Cytomat 2 C-LiN Series Automated Incubator delivers robust and reliable culture solution for cell-based pharmaceutical applications
Cellecta, Inc. Launches the First Commercially Available Dual-sgRNA Libraries for CRISPRa and CRISPRi Genetic Screens
Cellecta, Inc. Launches the First Commercially Available Dual-sgRNA Libraries for CRISPRa and CRISPRi Genetic Screens
Libraries of pooled lentiviral constructs that express two different sgRNA to all 19,000 human protein-coding genes improve overall gene activation or repression and generate more robust screening results
Novel Antibody-Drug Conjugates: Characterization Tools and Formulation/Process Development
Novel Antibody-Drug Conjugates: Characterization Tools and Formulation/Process Development
In this webinar, learn about antibody-drug conjugates (ADCs) and their function, how to analyze and characterize ADCs, and developing ADC processes and formulations.
Sartorius debuts the Intellicyt iQue3 at CYTO® 2019
Sartorius debuts the Intellicyt iQue3 at CYTO® 2019
Sartorius will be showcasing the latest addition to its cellular analysis portfolio on booth #103 at this year’s CYTO® conference and exhibition, with the launch of the Intellicyt iQue3.